TissueLabs logo

TissueLabs

TissueLabs combines 3D bioprinting systems and specialised biomaterials for laboratory tissue research.

ShareLink copied

The record

Vertical
Pharma & Drug Discovery
Sub-segment
Research biofabrication
Product type
Device
Headquarters
Bellinzona, Switzerland
Region
Europe

What they do

The official site lists TissueLabs SA in Bellinzona, Switzerland. Época Negócios describes it as a Brazilian biotech founded by CEO Gabriel Liguori and Emerson Moretto. Its biofabrication platform supplies researchers with 3D bioprinting systems and specialised biomaterials for creating tissues in the lab. The company describes engineering transplantable tissues and organs as a long-term goal, not a current product.

History and progression

How TissueLabs got here, step by step.

  1. 10 November 2026

    AI and Deep Tech pitch winner

    TissueLabs won the TOP AI & Deep Tech Startup Pitch Competition at Unicorn Factory Lisboa during Web Summit week, from 136 applications and seven finalists.

    Source

  2. 11 November 2026

    Second in KPMG global final

    As Brazil’s national winner, TissueLabs placed second in the KPMG Private Enterprise Global Tech Innovator 2026 global final in Lisbon.

    Source

Sources

  1. Link to Leaders competition report
  2. KPMG global final report
  3. Época Negócios reporting
  4. The HealthTech Signal: Web Summit Lisbon 2026 preview

Related companies

Is this your company? Feature it